217 related articles for article (PubMed ID: 22851868)
1. Vitamin D deficiency: correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4.
Schaalan MF; Mohamed WA; Amin HH
World J Gastroenterol; 2012 Jul; 18(28):3738-44. PubMed ID: 22851868
[TBL] [Abstract][Full Text] [Related]
2. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians.
El Husseiny NM; Fahmy HM; Mohamed WA; Amin HH
World J Hepatol; 2012 Aug; 4(8):242-7. PubMed ID: 22993666
[TBL] [Abstract][Full Text] [Related]
3. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
4. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
5. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease.
Reda R; Abbas AA; Mohammed M; El Fedawy SF; Ghareeb H; El Kabarity RH; Abo-Shady RA; Zakaria D
J Immunol Res; 2015; 2015():846348. PubMed ID: 26504859
[TBL] [Abstract][Full Text] [Related]
6. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
7. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
8. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents.
Ali ME; Halby HM; Ali MY; Hassan EA; El-Mokhtar MA; Sayed IM; Thabet MM; Fouad M; El-Ashmawy AM; Mahran ZG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696438
[TBL] [Abstract][Full Text] [Related]
9. Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection.
Yang XJ; Wang XO; Chen Y; Ye SD
World J Gastroenterol; 2020 Nov; 26(41):6378-6390. PubMed ID: 33244199
[TBL] [Abstract][Full Text] [Related]
10. Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus.
Abo-Shanab AM; Kholoussi S; Kandil R; Dorgham D
Lupus; 2021 Mar; 30(3):459-464. PubMed ID: 33183127
[TBL] [Abstract][Full Text] [Related]
11.
Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
[TBL] [Abstract][Full Text] [Related]
13. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
[TBL] [Abstract][Full Text] [Related]
14. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112
[TBL] [Abstract][Full Text] [Related]
15. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
Remmel T; Remmel H; Salupere V
J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
[TBL] [Abstract][Full Text] [Related]
16. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Ma HY; Dong L; Quan SZ; Li RY; Wang XR
Ann Palliat Med; 2021 Apr; 10(4):4108-4121. PubMed ID: 33832299
[TBL] [Abstract][Full Text] [Related]
18. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.
Kamal S; Madwar M; Bianchi L; Tawil AE; Fawzy R; Peters T; Rasenack JW
Liver; 2000 Jul; 20(4):281-9. PubMed ID: 10959806
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
El Guesiry D; Moez P; Hossam N; Kassem M
Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
[TBL] [Abstract][Full Text] [Related]
20. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
